Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Language
Publication year range
1.
Neurol Int ; 8(1): 6311, 2016 Apr 01.
Article in English | MEDLINE | ID: mdl-27127599

ABSTRACT

Thanks to the development of several new researches, the lifetime presented a significant increase, even so, we still have many obstacles to overcome - among them, manage and get responses regarding neurodegenerative diseases. Where we are in the understanding of neuroprotection? Do we really have protective therapies for diseases considered degeneratives such as amyotrophic lateral sclerosis and its variants, Parkinson's disease, Alzheimer's disease and many others? Neuroprotection is defined by many researches as interactions and interventions that can slow down or even inhibit the progression of neuronal degeneration process. We make some considerations on this neuroprotective effect.

2.
Revista Brasileira de Neurologia ; 2(27): 47-49, mar./abr. 1991.
Article | Index Psychology - journals | ID: psi-7771

ABSTRACT

Os benzodiazepinicos sao substancias utilizadas como ansioliticos e hipnoticos. Nos cinco continentes sao feitas mais prescricoes desses farmacos do que qualquer outro. No presente trabalho e feita uma revisao de seus mecanismos de acao, indicacao, efeitos colaterais e interacoes medicamentosas. Sao abordados tambem aspectos como tolerancia, dependencia e sindromede abstinencia, visando com que clinicos e neurologistas possam prescrever com mais seguranca esses medicamentos.


Subject(s)
Therapeutics , Anxiety , Substance Withdrawal Syndrome , Anti-Anxiety Agents , Benzodiazepines , Therapeutics , Anxiety , Substance Withdrawal Syndrome , Anti-Anxiety Agents
SELECTION OF CITATIONS
SEARCH DETAIL